Daegu, South Korea

Jong Heon Kim

This inventor holds 1 USPTO granted patent. Top assignee: Kyungpook National University Industry-Academic Cooperation Foundation. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jong Heon Kim. Retrieved from https://idiyas.com/inventor/jong-heon-kim-atgh8mqe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Jong Heon Kim in Neuroinflammatory Disease Treatment.

Introduction

Jong Heon Kim is an accomplished inventor based in Daegu, South Korea. He has made significant contributions to the field of neuroinflammatory disease treatment through his innovative research and patent.

Latest Patents

Jong Heon Kim holds a patent for a composition aimed at treating neuroinflammatory diseases. The patent, titled "Composition for treating neuroinflammatory disease comprising complement component 8 gamma protein or fragment thereof," focuses on the use of complement component 8 gamma protein or its fragments. This invention is particularly noteworthy for its potential to reduce the expression of inflammatory cytokines in microglia, which can alleviate abnormal behavior patterns associated with Alzheimer's disease.

Career Highlights

Jong Heon Kim is affiliated with the Kyungpook National University Industry-Academic Cooperation Foundation. His work has been instrumental in advancing the understanding and treatment of neuroinflammatory conditions.

Collaborations

He has collaborated with notable colleagues, including Kyoung Ho Suk and Jin Ha Han, to further his research and innovations in this critical area of health.

Conclusion

Jong Heon Kim's contributions to the treatment of neuroinflammatory diseases highlight the importance of innovative research in addressing complex health challenges. His work continues to pave the way for future advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…